Original
Triple terapia 10 días con esomeprazol 40 mg/12 h vs. cuádruple concomitante sin bismuto como tratamiento de primera línea de la infección por Helicobacter pylori
10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection
Ana Campillo
, Edurne Amorena, Miriam Ostiz, Marcos Kutz, Matilde LaIglesia
Autor para correspondencia
Aparato Digestivo, Hospital Reina Sofía, Tudela, Navarra, España
Leído
17766
Vecesse ha leído el artículo
1002
Total PDF
16764
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 51 | 0 | 51 |
| 2025 11 | 220 | 19 | 239 |
| 2025 10 | 263 | 17 | 280 |
| 2025 9 | 253 | 15 | 268 |
| 2025 8 | 188 | 26 | 214 |
| 2025 7 | 267 | 6 | 273 |
| 2025 6 | 171 | 5 | 176 |
| 2025 5 | 222 | 5 | 227 |
| 2025 4 | 270 | 8 | 278 |
| 2025 3 | 309 | 6 | 315 |
| 2025 2 | 322 | 11 | 333 |
| 2025 1 | 367 | 5 | 372 |
| 2024 12 | 289 | 2 | 291 |
| 2024 11 | 360 | 10 | 370 |
| 2024 10 | 331 | 4 | 335 |
| 2024 9 | 357 | 3 | 360 |
| 2024 8 | 300 | 13 | 313 |
| 2024 7 | 297 | 6 | 303 |
| 2024 6 | 284 | 6 | 290 |
| 2024 5 | 283 | 9 | 292 |
| 2024 4 | 315 | 6 | 321 |
| 2024 3 | 286 | 5 | 291 |
| 2024 2 | 249 | 4 | 253 |
| 2024 1 | 284 | 2 | 286 |
| 2023 12 | 232 | 7 | 239 |
| 2023 11 | 224 | 5 | 229 |
| 2023 10 | 287 | 10 | 297 |
| 2023 9 | 256 | 3 | 259 |
| 2023 8 | 338 | 2 | 340 |
| 2023 7 | 332 | 7 | 339 |
| 2023 6 | 277 | 8 | 285 |
| 2023 5 | 300 | 3 | 303 |
| 2023 4 | 236 | 9 | 245 |
| 2023 3 | 303 | 3 | 306 |
| 2023 2 | 200 | 8 | 208 |
| 2022 1 | 175 | 4 | 179 |
| 2022 12 | 157 | 15 | 172 |
| 2022 11 | 232 | 20 | 252 |
| 2022 10 | 238 | 22 | 260 |
| 2022 9 | 263 | 28 | 291 |
| 2022 8 | 225 | 18 | 243 |
| 2022 7 | 171 | 14 | 185 |
| 2022 6 | 143 | 21 | 164 |
| 2022 5 | 163 | 11 | 174 |
| 2022 4 | 144 | 12 | 156 |
| 2022 3 | 192 | 7 | 199 |
| 2022 2 | 196 | 7 | 203 |
| 2021 1 | 170 | 6 | 176 |
| 2021 12 | 139 | 13 | 152 |
| 2021 11 | 186 | 24 | 210 |
| 2021 10 | 135 | 15 | 150 |
| 2021 9 | 112 | 10 | 122 |
| 2021 8 | 140 | 20 | 160 |
| 2021 7 | 134 | 12 | 146 |
| 2021 6 | 101 | 31 | 132 |
| 2021 5 | 181 | 9 | 190 |
| 2021 4 | 305 | 21 | 326 |
| 2021 3 | 209 | 11 | 220 |
| 2021 2 | 179 | 8 | 187 |
| 2020 1 | 175 | 18 | 193 |
| 2020 12 | 151 | 7 | 158 |
| 2020 11 | 126 | 12 | 138 |
| 2020 10 | 92 | 10 | 102 |
| 2020 9 | 114 | 14 | 128 |
| 2020 8 | 127 | 11 | 138 |
| 2020 7 | 104 | 11 | 115 |
| 2020 6 | 96 | 10 | 106 |
| 2020 5 | 89 | 13 | 102 |
| 2020 4 | 128 | 10 | 138 |
| 2020 3 | 123 | 14 | 137 |
| 2020 2 | 101 | 10 | 111 |
| 2020 1 | 107 | 11 | 118 |
| 2019 12 | 90 | 16 | 106 |
| 2019 11 | 126 | 21 | 147 |
| 2019 10 | 145 | 19 | 164 |
| 2019 9 | 102 | 5 | 107 |
| 2019 8 | 91 | 3 | 94 |
| 2019 7 | 88 | 21 | 109 |
| 2019 6 | 142 | 37 | 179 |
| 2019 5 | 259 | 26 | 285 |
| 2019 4 | 135 | 26 | 161 |
| 2019 3 | 43 | 11 | 54 |
| 2019 2 | 36 | 13 | 49 |
| 2019 1 | 31 | 8 | 39 |
| 2018 12 | 35 | 8 | 43 |
| 2018 11 | 42 | 11 | 53 |
| 2018 7 | 0 | 1 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2017 12 | 1 | 0 | 1 |
| 2017 11 | 2 | 0 | 2 |
| 2017 10 | 1 | 1 | 2 |
| 2017 7 | 4 | 0 | 4 |
| 2017 6 | 2 | 0 | 2 |
| 2017 5 | 1 | 1 | 2 |
| 2017 4 | 2 | 0 | 2 |
| 2017 3 | 1 | 0 | 1 |
| 2017 2 | 1 | 1 | 2 |
| 2016 1 | 1 | 0 | 1 |
| 2016 12 | 1 | 0 | 1 |
| 2016 11 | 20 | 1 | 21 |
| 2016 10 | 15 | 3 | 18 |
| 2016 7 | 0 | 1 | 1 |
Mostrar todo
